Common
AtaiBeckley
American pharmaceutical company, subsidiary of Eli Lilly
AtaiBeckley
AtaiBeckley Inc. is a clinical-stage biotechnology company developing treatments for mental health disorders, including therapies based on psychedelics, entactogens, and related compounds. It was formed in November 2025 through the combination of atai Life Sciences N.V. and Beckley Psytech Limited, and has been a wholly owned subsidiary of Eli Lilly and Company since September 2026.
Open boosters, collect cards and trade them. Free to play.
Play for free